Category: Research
... JHH annually.
ESCaPMs are resistant to most common antibiotics, and the best treament for them is not known. Current treatment ... recommend using meropenem, one of the most powerful antibiotics in our armamentarium and the last line of defence against antbiotic resistant bacteria. Since overuse of particular antibiotics can lead to bacterial resistance (at a community or hospital ...
Category: Researcher Profiles
... that target neutrophilic inflammation such as macrolide antibiotics.
Identifying the mechanisms of neutrophilic inflammation - once ... controlled trials of macrolide therapy (a type of antibiotics) for patients with difficult asthma and more recently for patients ... grant in an Australia-wide multicentre study of macrolide antibiotics in asthma (AMAZES) which is nearing completion. At the time this ...
Category: News & Articles
A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is entering its ...
A national study investigating the use of antibiotics as a potential therapy for chronic asthma attacks is entering its ... “We showed in a previous study of 45 people that macrolide antibiotics can reduce inflammation and improve quality of life for people with ...
Category: News & Articles
... research is underway to test the effectiveness of combining antibiotics with commonly used treatments to help people with asthma better ... research is underway to test the effectiveness of combining antibiotics with commonly used treatments to help people with asthma better ... research is underway to test the effectiveness of combining antibiotics with current treatments to help people with asthma better control ...
Category: Researcher Profiles
... a new treatment for non-eosinophilic asthma with macrolide antibiotics. Eosinophils are a form of white blood cells in the immune system ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema.
Project ... Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which effectively ... of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema.
Project ... Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which effectively ... of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema.
... Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which effectively ... of COPD that we may be able to target with specific antibiotics. In addition, we have found 2 other bacteria, which have the ...
Category: Research
... We may be able to ingest specific microbes or use specific antibiotics or other factors as new treatments for emphysema.
Background: ... Microbiomes can be modified by microbial transfer, selective antibiotics and/or probiotics and their metabolic products, which effectively ... as well as during standard treatments with steroids and antibiotics in mice. 2. Assess for the same changes in gut microviomes in ...
Category: For Researchers
... the greatest challenges in medicine is the provision of new antibiotics in the face of increasing resistance. One solution may prove to be natural product biosynthetic engineering to create unnatural antibiotics, antivirals, and immunosuppressants.
The past two decades have ...
